HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical significance of vimentin expression and Her-2 status in patients with gastric carcinoma.

AbstractOBJECTIVES:
To determine whether vimentin could be used as a marker of gastric carcinomas with more aggressive behavior. To detect the extent of Her-2 status in gastric carcinoma and explore the correlation between vimentin expression and Her-2 status.
METHODS:
Vimentin expression was detected in surgically resected gastric carcinoma tissue specimens from 143 patients by immunohistochemistry. The human epidermal growth factor receptor 2 (Her2) status was evaluated by fluorescence in situ hybridization (FISH). Correlations between vimentin expression, Her-2 status and clinicopathological factors were evaluated using Kaplan-Meier method and Cox multivariate survival models.
RESULTS:
Vimentin expression was significantly correlated with age, advanced stage, poorly differentiated type, venous invasion, hepatic metastasis, and recurrence (p < 0.05). Her-2 gene was amplified in 16 (11.2%) out of the 143 gastric carcinoma tissue specimens. Her-2 status was correlated with advanced cancer, poor differentiation, venous invasion, hepatic metastasis, and recurrence (p < 0.05). The result of multivariate analysis showed that vimentin expression and lymph node metastasis were independent prognostic factors.
CONCLUSIONS:
Vimentin expression in epithelial cells of the surgically resected gastric adenocarcinoma tissue is an independent predictor of short survival, and Her-2 status shows a valuable correlation with clinical parameters.
AuthorsWenwen Zhao, Lu Yue, Fang Zhou, Congcong Xu, Wanhua Liang, Aihua Sui, Aiping Ding, Wensheng Qiu
JournalClinical and translational science (Clin Transl Sci) Vol. 6 Issue 3 Pg. 184-90 (Jun 2013) ISSN: 1752-8062 [Electronic] United States
PMID23751022 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013 Wiley Periodicals, Inc.
Chemical References
  • Vimentin
  • ERBB2 protein, human
  • Receptor, ErbB-2
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Cytoplasm (metabolism, pathology)
  • Female
  • Gene Amplification
  • Humans
  • Lymphatic Metastasis (pathology)
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Receptor, ErbB-2 (genetics, metabolism)
  • Stomach Neoplasms (genetics, metabolism, pathology)
  • Survival Analysis
  • Vimentin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: